z-logo
open-access-imgOpen Access
Evaluation of the effectiveness and tolerability of sunitinib and pazopanib in the first line treatment of metastatic renal cell carcinoma
Author(s) -
Senar Ebinç,
Ziya Kalkan,
Zeynep Oruç,
Zuhat Urakçı,
Mehmet Küçüköner,
Kaplan Ma,
Abdurrahman Işıkdoğan
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2021.0033
Subject(s) - pazopanib , sunitinib , medicine , tolerability , renal cell carcinoma , oncology , nausea , adverse effect , urology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom